| 2016 | Clinical Effect of Add-On Primovist-Enhanced Magnetic Resonance Imaging on Preoperative Tumor Staging in Hepatocellular Carcinoma Patients | 김태헌 | Article |
| 2017 | Current immunotherapeutic strategies in hepatocellular carcinoma: Recent advances and future directions | 김희영; 김휘영 | Review |
| 2021 | Identification and Functional Characterization of Two Noncoding RNAs Transcribed from Putative Active Enhancers in Hepatocellular Carcinoma | 김태수 | Article |
| 2023 | Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study | 이한아 | Article |
| 2021 | Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores | 이민종 | Article |
| 2024 | PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B | 김태헌; 김휘영; 이민종; 이혜아; 전호수; 이한아 | Article |
| 2020 | Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B | 남준열 | Article |
| 2020 | Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study | 이민종 | Article |
| 2016 | Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria | 김휘영 | Article |
| 2023 | The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA | 이한아 | Article |
| 2019 | Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study | 김휘영; 남준열 | Article |
| 2021 | Usefulness of Cone-Beam CT-Based Liver Perfusion Mapping for Evaluating the Response of Hepatocellular Carcinoma to Conventional Transarterial Chemoembolization | 최선영; 조수범 | Article |
